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Abstract Frailty is a health condition leading to many adverse clinical outcomes. The relationship between frailty and
advanced age, multimorbidity and disability has a significant impact on healthcare systems. Frailty increases cardio-
vascular (CV) morbidity and mortality both in patients with or without known CV disease. Though the recognition
of this additional risk factor has become increasingly clinically relevant in CV diseases, uncertainty remains about
operative definitions, screening, assessment, and management of frailty. Since the burdens of frailty components
and domains may vary in the various CV diseases and clinical settings, the relevance of specific frailty-related
aspects may be different. Understanding these issues may allow general cardiologists a clearer focus on frailty in
CV diseases and thereby make more tailored clinical decisions and therapeutic choices in outpatients. Guidance on
identification and management of frailty are sparse and an international consensus document on frailty in general
cardiology is lacking. Moreover, new options linked with eHealth are going to better define and manage frailty. This
consensus document on definition, assessment, clinical implications, and management of frailty provides an input to
integrate strategies pre- and post-acute CV events with a comprehensive view including out of hospital, office-
based diagnostic and therapeutic choices, and based on a multidisciplinary team approach (general cardiologists,
nurses, and general practitioners).
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Introduction
Ageing leads to pathophysiological changes, the coexistence of sev-
eral pathological conditions, malnutrition and inactivity, producing a
negative impact on health status. These changes, often combined
with poor socioeconomical factors, may lead to the development of
frailty, which is characterized by a decreased physiologic reserve and
ability to maintain homeostasis leading to increased vulnerability to
stressors and increased risk of adverse health outcomes.1,2
The frailty status is attracting increasing attention due to popula-
tion ageing, its major implications for clinical practice, the opportunity
to contrast an accelerated clinical decline, and the magnitude of im-
pact on healthcare systems.3 For these reasons in cardiology practice,
frailty evaluation deserves to be included as part of the general elder-
ly clinical assessment.4–7
A recent position paper from the Acute Cardiovascular Care
Association (ACCA) of the European Society of Cardiology (ESC)8
analysed the impact of frailty on patients mainly in the acute cardiac
and critical care setting. Moreover, a document from the Heart
Failure Association (HFA) of the ESC focused on frailty as a relevant
clinical aspect in complex patients with heart failure (HF).9
However, much of cardiac patients’ management takes place in an
elective care setting and this allows greater scope for pre-assessment
and improvement of frail patients’ physiological status, prior to any
treatment, procedure or intervention.

















































Therefore, the aim of our paper is to integrate strategies both pre-
and post-acute cardiovascular (CV) events, to develop a comprehen-
sive view, encompassing out of hospital, office-based diagnostic and
therapeutic choices, and based on a multidisciplinary team approach
(general cardiologists, nurses, and general practitioners). This ap-
proach should allow the development of a structured management
plan, identifying the best treatment for the main CV conditions, but
also including home care and social support to family and community




The multifaceted dynamics between underlying physiological
changes, chronic diseases, and simultaneous presence of various
pathological conditions can result in health states in older ages that
are not captured by traditional disease classifications, and that are
commonly known as geriatric syndromes.10 Disease-based conceptu-
alization may be an inadequate proxy for health in elderly subjects.
Rather than the presence or absence of a disease, the most important
consideration for older people is likely to be the comprehensive as-
sessment of their functioning.10
Various definitions of frailty have been proposed to identify and
quantify this complex condition. Frailty has been defined as a loss of
functionality leading to an increased vulnerability to adverse stress
and health events or as a medical syndrome with multiple causes and
contributors that is characterized by diminished strength, endurance
and reduced physiologic function that increases an individual’s vulner-
ability for independency, loss and/or death.1,11
McDonagh defined it as a multidimensional syndrome with
increased vulnerability to acute stressors, such as hospitalization, falls
and infection,12 whereas in the Frailty Operative Definition-
Consensus Conference Project13 the Experts agreed on a more
comprehensive definition of frailty including the assessment of physic-
al performance, gait speed and mobility, nutritional status, mental
health, and cognition.
Frailty contributors derive from cellular and system physiology
alterations, including sarcopenia, reduced nutritional intake, and low
physical activity, in addition to associated CV and non-CV chronic
diseases.14
Recently, neuropsychiatric status, including cognitive impairment
and depression, alcohol consumption, and social conditions such as
social isolation and loneliness have been shown to contribute to
frailty.15–19
Comorbidity and disability
Multimorbidity or comorbidity (i.e. the concurrent presence of two
or more medically diagnosed diseases in the same individual) are fre-
quently associated with frailty and closely related to ageing20–24 and
disability (i.e. difficulty or dependency in carrying out activities
essential to independent living, including self-care tasks, living inde-
pendently at home, and important desired activities for quality of
life—QoL).25 Therefore, although frailty is a distinct condition over-
laps with both comorbidity and disability. Indeed, both frailty and
comorbidity predict disability.25 However, some patients present
with frailty alone (e.g. a young homeless person with excess of alco-
hol assumption and cardiomyopathy) or only multimorbidity (a com-
pensated HF patient with treated diabetes and hypertension) or only
disability (a young paraplegic person participating in the Paralympics
games) (Box 1).
Frailty components and domains
During clinical evaluation, the identification of the main components
leading to a clinically relevant frail condition or to the loss of self-care
in the individual patient can direct the healthcare team towards the
unique needs and the personalized solutions for the subject (Figure 1).
The burdens of frailty components found at clinical evaluation may be
related to the specific settings and purpose of the evaluation. For ex-
ample, older patients evaluated during hospitalization for acute events
or in geriatric communities may more frequently present with social
frailty or advanced cognitive impairment than subjects presenting in a
cardiology out-patient clinic who are being evaluated for an elective
procedure. In the latter patients, the physical frailty burden or multi-
morbidity may be more relevant for interventional choices.
Various domains of frailty including a medical domain, a physical
domain, a cognitive/depressive status domain and a social domain
have been identified in the assessment of patients for interventions.26
Inclusion of frailty measures in diagnostic algorithms might allow
healthcare providers to increase risk prediction capability and
Box 1. Definitions.
FRAILTY: 
Multidimensional and multisystem condition characterized 
by decreased functional reserves and increased 
vulnerability to stress and acute adverse events.
This condition, a complex system behavior of components, 
can be described according to: 
a) peculiar genesis, including accumulation of damages 
and dysregulations, 
b) peculiar phenotype including physical, nutritional, 
cognitive/psychological and social aspects, and 
c) adverse health-related outcomes
MULTIMORBIDITY:
Concurrent presence of two or more medically diagnosed 
diseases in the same individual, closely related with ageing
DISABILITY:
Difficulty or dependency in carrying out activities essential 
for daily living, including tasks needed for self-care and 
living independently 
OVERLAPPING CONDITIONS:
Ageing is associated with frailty, multimorbidity and 
disability and the three conditions are largely overlapping. 
































































.thereby make better-founded decisions with more efficient use of
healthcare resources, whereas instruments that can disentangle single
components of frailty domains would be useful to tailor specific inter-
ventions in each patient.
It is important to note that frailty is a dynamic phenomenon, with
the possibility of partial restoration of functional independence after
temporary disability to a frail or pre-frail individual, depending on the
main component leading to loss of self-care. For instance, hospitaliza-
tion for infection or HF can precipitate a disability status that can be
partly reversed after a few weeks of increased family support, where-
as installing of long-term social support may be useful in a patient pre-
senting with a high degree of social frailty. Indeed, long-term follow-
up data among frailty states have been reported from 16 studies,
showing improved health status in 13.7% [95% confidence interval
(CI) 11.7–15.8%], worsening in 29.1% (25.9–32.5%) and maintenance
of the same frailty status in 56.5% (54.2–58.8%) over about 4 years.27
Evaluation of frailty
Various indices and scores, validated as predictive of mortality
and/or adverse clinical outcomes in several clinical settings, have
been proposed to quantify this multisystem complex condition.
Among the operational definitions, there are two basic concepts
of frailty: the phenotype model and the cumulative deficit
model.28 Fried et al. in 2001 have proposed an operational defin-
ition of ‘phenotype’-based frailty syndrome (Supplementary ma-
terial online, Tables 1aS and 1bS), based on the presence of at
least three out of five criteria, i.e. unintentional weight loss/sar-
copenia, weakness, poor endurance/exhaustion, slowness, and
low physical activity level. The identification of one or two items
confers an intermediate frailty phenotype or a pre-frail status.1
Other indices have been proposed: the Short Physical
Performance Battery (SPPB), which is measured by three timed phys-
ical performance tests—tandem balance, gait speed, and chair raise,
the 5-m gait speed, the Study of Osteoporotic Fractures (SOF)
index—presence of at least two among unintentional weight loss
>5%, inability to raise from a chair five times without using arms and
reduced energy level—and the simple Frail Scale.11,14,29–32
Alternatively, the Frailty Index (deficit accumulation), defined by
Rockwood et al.33 is a 70 item form based on the accumulation of
specific deficits (including functional limitations and disabilities, cogni-
tive and sensory impairment, psycho-social variables and a number of
diseases). The Authors further developed the 7-point and the 9-point
Clinical Frailty Scale (a semi-quantitative global judgement)
(Supplementary material online, Figure 1S), which was shown to be
highly correlated with the Frailty Index.34
Therefore, albeit under the same definition, these two different
concepts currently recognize completely different subjects and,
more importantly, generate different clinical and prognostic implica-
tions that may be considered as complementary.35–37
The likelihood of multiple overlapping issues may be better
explored across several domains and therefore involves several disci-
plines.38 Frailty is one of several domains explored within the
Comprehensive Geriatric Assessment (CGA) a multidimensional
interdisciplinary diagnostic process.39
The CGA-derived Multidimensional Prognostic Index40 includes
information on functional basic and instrumental activities of daily liv-
ing, cognitive and nutritional status, comorbidities and medications.41
Alternatives include the multidomain-evaluating Edmonton frail
scale42 and a variety of questionnaire-based tools.43–48 Moreover,
some evaluation techniques have been validated to allow the assess-
ment of large electronic data records based on electronic diagnostic
codes.49
The recently published guidelines by the task force of the
International Conference of Frailty and Sarcopenia Research suggest
the use of a validated simple evaluation technique, suitable for the
specific setting or context, possibly directing the patient towards a
more complex CGA after the identification of frailty.50 Although a
standardized CGA may not be routinely performed in clinical prac-
tice, there is sufficient evidence to recommend that all persons older
Figure 1 Components of frailty that contribute to reach a frailty status. In subjects who reach the threshold for frailty, the burden of various com-
ponents is expressed differently. The figure exemplifies how common frailty-related conditions occur differently in frail patients (Pts) to determine
the threshold for frailty or loss of self-care and how other numerous (N) potential frailty components may be present in other N Pts.

































































































than 70 years should be screened for frailty by healthcare
providers.11
Finally, several tools have been proposed for the assessment of
multimorbidity, including the Acute Physiology and Chronic Health
Evaluation (APACHE) score, the Charlson Comorbidity Index and
the Cumulative Illness Rating Scale.51–53 The Basic Activities of Daily
Living, the Intermediate Activities of Daily Living and the Advanced
Activities of Daily Living scores are the most commonly used tools to
assess functional dependence, which represents the core of
CGA.54,55
Screening for frailty in cardiology
Frailty screening tools should be sensitive, specific, quick to adminis-
ter, validated for screening, and not requiring specific
equipment.11,14,28,32
Table 1 lists some of the recommended techniques for initial evalu-
ation of frailty in CV diseases,4,6,56,57 highlighting the domains and
components investigated by the instruments. Of course, some of
these methods are only part of an initial identification of frailty (e.g.
where laboratory parameters or data from electronic medical
records are used together with other information), and ideally the
approach to frailty evaluation should be inclusive of all the various
domains of frailty.
The ideal technique to screen and assess frailty in any given situ-
ation should be chosen according to the characteristics of the sub-
jects, the aim of the assessment and the clinical context. Assessment
of frailty for epidemiological purposes or in a clinical context is differ-
ent. Frailty has particular implications in particular CV diseases and in
some of them specific frailty assessment tools have been more
studied and validated than in other pathological conditions. For ex-
ample, the HFA has recently suggested that HF may be better
assessed by a multidimensional assessment approach rather than
using tools focusing on physical frailty.9 In some situations, different
assessment techniques have different advantages, for example, in
older patients who are candidates for complex intervention, indices
exploring frailty multidomains (as in the Frailty Index or the
Multidimensional Prognostic Index) might be better predictors of
death, whereas indices exploring physical frailty (such as the Fried cri-
teria, or the SPPB and gait speed) may be more helpful to identify
patients at risk of complications and worsening disability.
It is unlikely that one assessment fits all, and when screening has
identified a frail condition, it may be necessary to go through a further
in depth assessment of the patient with a comprehensive geriatric
evaluation or alternatively further focus on the specific deficit using
tailored assessments. For instance, specific cognitive tools or comor-
bidity and/or disability tools may be administered if a cognitive impair-
ment or multimorbidity has been evidenced. Throughout the
assessment process, it should be reminded that the relevance of
frailty identification lies in the opportunity it provides to intervene on
potentially modifiable components to improve QoL (Figure 2).
Digital technology and eHealth for frailty
evaluation
eHealth covers newer technologies such as telehealth, mHealth,
wearables such as heart rate and activity tracking, utilization of
artificial intelligence for analysing non-linear biological information,
and sensor technology.
Several characteristics associated with frailty are highly suitable for
detection and monitoring using technology-based measurements.
Information, such as physical activity, gait speed, postural transitions
and falls, can be readily detected with current activity and fitness
tracking technologies.58–61 Heart rate and fitness tracking may iden-
tify early markers of disease62,63 or the presence of arrhythmias, and
consumer-level products already have widespread use in non-frail
individuals.64 Other clinical information such as cognitive, visual, or
sensory impairments potentially might be assessed through telehealth
or mHealth technologies and thereby be available for primary or sec-
ondary healthcare providers. Sensor technologies are available for
other relevant physiological information such as haemoglobin con-
centration, oxygen saturation, and skin temperature and could there-
fore contribute to the identification and management of frail
individuals.65,66
Epidemiology, morbidity,
mortality, and consequences of
frailty in cardiovascular diseases
Incidence and prevalence
The reported frailty prevalence is highly heterogeneous, closely de-
pendent on the population studied, the clinical setting where the
study is conducted (i.e. in hospital database, primary care, outpatient,
geriatric clinics, community-based samples, etc.) and on the measure
indexes used. A meta-analysis based on 62 papers reporting data
from 22 European countries showed an overall estimated frailty
prevalence of 18%, ranging from 12% in 53 community-based studies
to 45% in 15 non-community-based studies, with a prevalence of
12% in community studies adopting a physical phenotype and 16%
for all other definitions.67
Besides the clinical phenotype and the presence of multimorbidity,
depression is strongly associated with frailty, high levels of loneliness
are related to an increased risk of becoming physically frail, and socio-
economic status affects the risk of frailty, multimorbidity and
disability.15,18,19
In a population-based cohort of 12 844 people aged >65 from six
Latin American countries, where nearly 40% had none or some edu-
cation but did not complete primary school, depression was associ-
ated with an increased hazard of incident frailty.68 Prevalence of
frailty and pre-frailty appear higher in community-dwelling older
adults in upper middle-income countries, compared with high-in-
come countries. There is limited evidence on frailty prevalence in
low middle-income and low-income countries.69
Clinical significance of frailty in
cardiovascular disease
The prognosis of frail patients is worse than that of robust subjects, is
directly influenced by frailty severity, can be evaluated by different
indexes and tools, and by its association with disability and comorbid-
ity. This relationship has been described both for adverse CV out-
comes and non-CV mortality, across various settings, different
diseases and subpopulations.70–78











Table 1 Initial evaluation of Frailty in CV disease
Instrument Frailty domain Components Test Score
5-m gait speed test Physical function Slowliness Patient is positioned behind start
line and asked to walk at a
comfortable pace past 5-m fin-
ish line; cue to trigger stop-
watch is first footfall after start
line and first footfall after finish
line; average of three times
Slow: <0.83 m/s (>6s)
Very slow: <0.65 m/s (>7.7 s)
Extremely slow: <0.50 m/s (>10
s)
Handgrip strength test Physical function Weakness Patient is asked to squeeze a
handgrip dynamometer as hard
as possible; repeated three
times (once with each hand
and then with strongest hand);





Physical function Many questionnaires have been
validated; some provide a
measure of activity in kcal/






CES-D questionnaire Physical function Exhaustion Two questions administered:
How often in the past week
did you feel like everything you
did was an effort?/like you
could not get going? [often (i.e.
>_3 days) or not often (i.e. 0–2
days)]







Gate (5 min gate)
Balance:
Patient is asked to stand in semi-
tandem position for 10 s; if pa-
tient is able, then he/she is
asked to stand in full tandem
position for 10 s; if patient is
not able, then he/she is asked
to stand in side-by-side position
for 10 s
Chair rise:
Patient is seated on a straight-
backed chair and asked to stand
up five times as quickly as pos-
sible without using arms; time





0 = side by side 0–9 s or unable
1 = side by side 10 s
2 = full tandem 0–2 s
3 = full tandem 3–9 s
4 = full tandem 10 s
Chair rise:
0 = unable
1 = >_16.7 s
2 = 13.7–16.6 s
3 = 11.2–13.6 s




Each item is scored 0–4
Frail if composite score <_5/12
Weight loss Medical domain Nutritional status
Shrinking
Self-reported or measured unin-
tentional weight loss
>_10 lbs (>_4.54 kg) in past year





















































..CV mortality seems higher in frail [N = 540; hazard ratio (HR) 2.79,
95% CI 2.35–3.30] and pre-frail (N = 2188; HR 1.64, 95% CI 1.45–
1.85) community-dwelling adults aged 60 or older than in 2244 ro-
bust participants in the cross-sectional National Health and Nutrition
Survey from 1999 to 2004.79
When the relationship between frailty and CV disease was consid-
ered in 1432 older adults from the Longitudinal Aging Study
Amsterdam, the frailty risk was increased in those with peripheral ar-
tery disease and HF.80
A meta-analysis including 31 343 subjects showed that frailty as
well as pre-frailty were associated with any type of CV disease
(pooled risk estimates: total: HR 1.70, 95% CI 1.18–2.45, —from HR
1.26, 95% CI 0.98–1.63 to HR 3.40, 95%CI 1.80-6.41—; total: HR
1.23, 95% CI 1.07–1.36, —from HR 0.13, 95% CI 0.93–1.38 to HR
3.10, 95% CI 1.61–5.95—, respectively).81 Moreover, frailty was also
associated with a 3-fold higher risk of CV death in six prospective
cohorts including 18 307 participants over a median of 4.4 years
(range 1–11.4).81
The degree of pre-frailty expressed as the number of Fried criteria
has been shown to be related to incident CV events over a
4.4 ± 1.2 years follow-up in a prospective cohort of 1567 community-
dwelling individuals aged >65 years without CV disease, frailty or dis-
ability at baseline.7
Multiple mechanisms (poor physical activity, sub-clinical vascular
and cardiac alterations, oxidative stress, deoxyribonucleic acid dam-
age and shorter telomere length, inflammatory markers, endocrine
dysregulations, accelerated cellular senescence and epigenetic modi-
fications) may contribute to the association between frailty and
symptomatic CV disease.82–84 The higher risk has been also linked to
reduced treatments, considered futile or risky in subjects perceived
to be frail. This behaviour may lead to greater occurrence of comor-
bidity and disability in frail patients instead, further worsening their
prognosis. However, the risk of non-CV death should be taken into
consideration when assessing the CV death risk and clinical decision
making in the frail population. Indeed, when assessing the cause of
death in relation to the baseline frailty status among 3135 commu-
nity-dwelling older men in the MrOS Sleep study in an average fol-
low-up of 9.2 years, the multivariable-adjusted risk of CV death
among frail versus robust men was 1.38 (95% CI 0.99–1.92) using the
competing risk method versus 1.84 (95% CI 1.35–2.51) using the
traditional Cox proportional hazards method.85
....................................................................................................................................................................................................................
Table 1 Continued










Non applicable Non applicable





See Table 1aS and 1bS
Supplemental materials
See Supplemental materials
Clinical frailty scale Medical domain Semiquantitative (generic) See Figure 1S Supplemental
material
See Supplemental materials






See Figure 2 Ssupplemental
material
Four-item test:
chair stands, cognitive impairment
(Mini-Mental State Examination
or recall three out of three
words after a distractive task),
measured lab serum haemoglo-
bin, and serum albumin
The tool is scored 0 (least frail)
to 5 (most frail)
Chair:




score of <24 on the Mini-Mental
State Examination (which is
highly unlikely if the patient is
able to correctly recall three
out of three words after a dis-
tractive task and may obviate
the need for further cognitive
testing)
Lab (see above)































































































Frailty models in specific contexts
of cardiovascular diseases
Frailty has been evaluated in many different fields of CV diseases.86–243
A detailed discussion of frailty models and frailty implications in
patients’ management is provided in the Supplementary material on-
line, Annexe 1. In particular the following chapters are detailed: Frailty
and CV prevention (Arterial Hypertension, Dyslipidemia), Cronic cor-
onary syndrome, Arrhythmias (Atrial fibrillation, Cardiac Implantable
Electronic Devices), Valvular heart diseases (see a proposed rapid min-
umum screening in patients considered for transcatheter aortic valve
replacement160, Figure 3), Chronic heart failure, Peripheral vascular dis-
ease, Coagulation and antithrombotic therapy.
The ‘patient trajectory’ before,
during, and after critical illness
and towards the end of life
Mapping the trajectory of chronic conditions against known disease
patterns can help healthcare professionals clarify the type and timing
of care required for each individual patient. In the literature there are
three distinct trajectories described for people with chronic
conditions: the cancer trajectory, the chronic organ/system failure
trajectory and the frailty trajectory.245,246
The ‘cancer trajectory’ is characterized by a predictable decline in
physical health and function and impaired ability for self-care, usually
with a clear terminal phase.245,247
The ‘chronic organ/system failure trajectory’ includes conditions
such as HF and is characterized by a progressive functional decline
with occasional acute exacerbations. During exacerbations, for ex-
ample, the unplanned admissions due to an episode of acute HF, the
mortality rate is high.245 In this trajectory, the timing of death is un-
certain, making both discussing and initiating the end of life care plan
difficult.248
Finally, the ‘frailty trajectory’ includes patients of older age with
brain failure or generalized frailty. It is characterized by progressive
disability with no clear terminal stage.245 During this trajectory, an
acute event such as pneumonia, may lead to death. Several studies
have indicated that frailty is the predominant predictor of poor out-
comes such as in-hospital mortality, hospitalization, disability, func-
tional decline, and treatment complications.249–252 Despite these
differences among the chronic conditions, at the end of life, patients
may take on one or more of the trajectories described above.
More recently, Freiheit et al., have described a frailty trajectory for
people diagnosed and treated for coronary artery disease as having a
U-shape, where the Frailty index declines significantly after the initial
treatment and then rises after a period of time.115
It is estimated that 40% of deaths occur in frail people who have
no clear diagnosis, which suggests that the identification of palliative
care needs must take into account the different frailty domains and
not only disease-centred variables.253 Frailty seems to be the most
prevalent condition at the end of life. Therefore, in clinical practice,
frailty must be considered quantitatively to determine the reserve
level of the patient.251,252
Palliative care in patients with progressive chronic conditions
involves optimizing QoL in order to facilitate a peaceful death. An
understanding of disease trajectories can be helpful to healthcare
professionals in this regard, to predict when progressive deterior-
ation and death may occur. If palliative care is considered only at a
late stage, patients and their families may miss opportunities to bene-
fit earlier in the illness.254 A realistic conversation about the disease
trajectory between the patient, family and healthcare professionals
can increase supportive care and focus on QoL and symptom
control.253,255
End-of-life care provision and the patient’s acceptance that
death is imminent is different among the trajectory types
described before.255 So, when designing their care, engagement
with patients and caregivers should commence relatively early
and include good communication and education, close attention
to the patients’ needs, symptoms and preferences, as well as
periodic re-evaluation of the care provided and flexible plan-
ning.256 It has recently been proposed that there is a need for so-
called “balancing factors” in the management of frailty, i.e. intrin-
sic and extrinsic resources to meet patients’ psychological, so-
cial, physical, environmental and/or cognitive frailty challenges
and greater focus on how older peoples’ wellbeing may be pro-
tected and promoted, than how frailty can be resolved or dimin-
ished, if sufficient resources are available.257
Figure 2 Frailty evaluation. If the presence of frailty is identified
after screening, or the patient is presenting a manifest form of frailty,
a more detailed assessment of the specific deficit evidenced or a
comprehensive geriatric assessment is indicated. It is a crucial step
to recognize the frailty domains, their components and their relative
weight in order to give a tailored personalized response to the
patients’ peculiar needs.


























































Identification and management of
frailty in general cardiology
In a speciality such as cardiology where there are many invasive treat-
ments available, the assessment of frailty is key for determining the
appropriatness of these interventions. Therefore, in cardiology prac-
tice, screening for frailty should be performed as a minimum in the
subjects listed in the Box 2. If one or more frailty domains are identi-
fied, the patient should then undergo a more comprehensive evalu-
ation (Figure 2).
Besides general support to frailty as discussed below, the identifica-
tion of the specific needs from the individual’s frailty components
should be addressed to tailor intervention.
There is still debate about the effectiveness of specific actions
aimed at modifying the natural course of frailty. However, there is
current consensus that physical frailty is potentially, at least in part,
reversible and that self-care maintenance can be improved by appro-
priate intervention.258,259 In addition, the detection of frailty in the
preoperative assessment of older candidates for elective complex
cardiology procedures might suggest that there is potential benefit
from a short period of more intense exercise training and nutritional
support in order to reduce the risk of complications and increase the
probability of functional success (Box 3).
Cardiac rehabilitation
Cardiac rehabilitation programs usually include patient evaluation
both before and after the program and have a specific focus on nutri-
tion and exercise. Multicomponent programs are important for frail
patients, as the EAPC position paper on frailty emphasises260 and are
designed to improve the prognosis of old frail individuals and/or give
benefits in terms of QoL. However, they need to be carefully
designed and individually tailored, depending on the severity of frailty
and the existence of CV disease and comorbidities, to achieve the
best results safely.
During rehabilitation after an acute CV event, in a large number of
frail patients, finishing the program was related to an improvement in
frailty levels, although greater frailty was associated with higher drop-
out.261
Nutrition, exercise and combined
interventions
Nutrition is a very important part of the multidimensional interven-
tion in the very elderly and frail or sarcopenic/cachectic patients,262
poor nutritional status being one of the main pathophysiological
mechanisms for frailty. A systematic review on nutrition in old frail
individuals reported an association between low intake of specific
micronutrients and the frailty syndrome, and an association of higher
protein and higher dietary antioxidant intake and lower risk of
frailty.263 Although not unequivocally demonstrated, it was suggested
that improving nutritional status may reduce the risk of frailty and
that nutrition may improve the functional outcome of elderly and frail
patients.259,264–272
We highlight the importance of dental care, quantitative (energy
intake) and qualitative (nutrient quality) factors of nutrition in the op-
timization of the frailty syndrome management.
Exercise in older people was shown to confer beneficial effects on
body composition, muscle function, and functional ability.273,274
However, the effects of exercise intervention on physical functioning
of old frail people have been evaluated in very few trials. In frail elder-
ly, moderate intensity aerobic and resistance training exercise pro-
grams increased the risk of falls and are not advised whereas it is
thought that weighted low-intensity strength training could be indi-
cated in most frail people.275–277 Specific sessions on balance training
using adapted tai-chi exercises have been shown to be beneficial in
the prevention of falls, but hip protectors should be used and envir-
onmental modification may be required to avoid problems.275–277
Interventional trials designed to evaluate the benefits of cognitive
training often combined with other interventions in reversing frailty
and its physical manifestations, showed the possibility of reversing the
degree of frailty.267,278–283
Other interventions and role of eHealth
in frailty management
Other key areas for consideration include avoiding inappropriate
prescribing and polypharmacy, careful selection of medical and surgi-
cal interventional procedures, planning for a shorter stay in hospitals
where possible and long-term support after any discharge.
Inappropriate prescribing has been consistently demonstrated to be
associated with increased risk of hospitalization, geriatric syndromes
and mortality in older adults in several settings.284–286 The Beers cri-
teria in North America, and the STOPP-START criteria in Europe,
are the screening tools most widely used in geriatric medicine to
avoid potentially inappropriate prescriptions, to alert doctors to the
most appropriate treatment, to adjust doses of drugs according to
renal function, and to identify drug–drug interactions known to be
associated with harm in older adults.287–289
Figure 3 Short multidomain screening (proposed as minimum
screening in patients considered for transcatheter aortic valve re-
placement) including the Essential Frailty Toolset, malnutrition, de-
pression and disability screening (Piankova and Afilalo, Cardiol Clin,
2020, see online annexe 1).





















..There is at present insufficient evidence to recommend specific e-
Health-related interventions for frail individuals.290 Although no con-
trolled data are available on clinical outcomes, the use of e-Health has al-
ready become part of daily monitoring of some frail patients who live
independently (for instance videocameras which are monitored by family
members using phone apps so they can intervene rapidly if health threat-
ening circumstances occur—falls, syncope, etc.—, alerting devices to re-
member the timing of drug assumption, thus increasing adherence, . . .).
Although several issues must be addressed before these tech-
nologies can be generally recommended, technology-based risk
stratification may, however, be used for personalized manage-
ment of individuals at risk and may, in the near future, not only
identify high-risk individuals but also aid in the choice of interven-
tion suited for the frail individual.61,291 New studies are needed
to determine which the best protocols for frailty management
are.
Box 3. Management of frailty.
MANAGEMENT OF FRAILTY:
Focus on: 
Nutrition (from dental care to dietary counselling and prepared meals)
Exercise (tailored exercise)
Cognitive domain / emotional support (cognitive and emotional interventional approaches)
Cardiac rehabilitation multi-component program 
(after an acute event, possibly before programmed interventions/procedures)
Focus on enviromental aspects to reduce falls 
(such as avoiding architectonic barriers at home, carpets, etc)
Target inappropriate polypharmacy
Reduce the hospitalization periods when needed
Support self-care behaviour 
(- intensify the support to the patients when needed, for instance after an acute event 
- support sensory impairment
- act at a community level if the individual or family level of support are inadequate)
Consider potential new interventions from eHealth technology
Box 2. Identification of frailty.
IDENTIFICATION OF FRAILTY: 
patients ≥ 70 years with an acute or chronic CV disease 
patients ≥ 70 years with a chronic CV disease with worsening of chronic health conditions  
patients with a CV disease known to be closely related to frailty such as HF and AF 
or presenting multi-morbidity 
patients ≥ 70 years with CV disease hospitalized for:
CV acute events
or non CV acute events 
or undergoing  major surgery
patients ≥ 70 years candidate to cardiac interventional procedures (PM, ICD-CRT, TAVR, PCI, etc.)
























































..Special role for the cardiovascular
team
Development of a structured integrated management plan for
frailty in cardiology should be the responsibility of a multidisciplin-
ary team which includes nurses, general practitioners, and cardiol-
ogists, with a role for geriatricians when in-deep assessments are
needed (Box 4, Supplementary material online, Annexe 2).
Professionals acting as part of the frailty team are involved in spe-
cific clinical aspects to optimize the frail patient peculiarities and
management (Figure 4).
Future perspectives
The progressive increase of the elderly population is stressing
world health systems. The frailty epidemic is growing and the
improvement in acute and chronic disease management will increase
the number of older patients and therefore more prone to become
frail.
Frail patients are often excluded from large CV trials and the cardi-
ology societies should design studies to target frail patients. Although
most guidelines are suggesting careful attention to age, co-morbidities
and frail-associated components (body size, mobilization, kidney
function, cognitive status, nutritional assessment, and life expectancy),
frail patients’ management at the moment generally follows the rec-
ommendations as non-frail subjects.
The use of standardized methods for frailty evaluation could
allow clinicians to use common criteria to interpret the results
from different studies. However, the current heterogeneity of the
available screening and assessment tools should not limit the rou-
tine assessment of frailty in daily practice, avoiding the use of the
clinical subjective judgments (eyeball test or foot-of-the-bed
assessment).
The identification of frailty according to simple, validated,
universally accepted methods will allow us to define the additional
risk frailty brings and possibly aid the frailty health team to
Box 4. The frailty health team.
SPECIAL ROLE FOR GENERAL CARDIOLOGISTS
Pursuing prevention of cardiovascular diseases
Consider specific treatment aspects of cardiovascular diseases
Improve cardiovascular protocols impacting on frailty
Clinical evaluation of frailty in single patient
Use of tools addressing specific issues
SPECIAL ROLE FOR GENERAL PRACTITIONERS
Initial screening for frailty and contact with specialists
Informing the patient and meeting the patient’s family
Planning for the patient support: the interface with the primary care
Monitoring the patient with frailty
Clinical management of frailty
SPECIAL ROLE FOR NURSES
Follow a holistic, individualized, person-centered approach
Intervention impacting on frailty aimed at maintenance of homeostasis
Case/care management
Figure 4 The frailty galaxy: specific peculiarities in general cardiology.


























tailor CV and non-CV interventions to optimize the clinical
outcomes.
New epidemiological and clinical challenge such as world pandem-
ics are going to reconsider the whole health system clinical pathways.
In this view a comprehensive evaluation of multimorbidities and frail
profiling is going to be required to stratify the global risk of elderly
patients.
In older frail patients the goals of treatment have to be shared with
the patients, taking into account the patients’ needs and attainable
objectives, and frailty-directed specific interventions.
Digital health will probably have a prominent role in CV medicine
in frail individuals for identification, monitoring, and personalizing
treatment.
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